Does nicorandil instead of supranormal potassium safely provide cardioplegia?

Completed

• Conditions: Angina pectoris; Circulatory System

• Registration Number: ISRCTN66723294
• Lead Sponsor: niversity Hospital of North Norway (Norway)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-09-25
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Aged 40 to 75 years
2. Elective to Coronary Artery Bypass Graft (CABG)
3. Ejection Fraction (EF) more than 40%

Exclusion Criteria

1. Concomitant procedures
2. Emergency procedures
3. Glibenclamid medication
4. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Creatine Kinase Myocardial Band (CKMB)<br>2. Troponin<br>3. Cardiac Index (CI)<br>4. Saphenous Vein (SV)<br>5. Systemic Vascular Resistance (SVR)<br>6. Heart rate (HR)<br>7. Time to arrest

Secondary Outcome Measures

Name	Time	Method
Quality of life